The markets opened lower with the Dow tumbling 84 points to 14,988 as the government shutdown continued. Nasdaq fell 14 points to 3793.
On the upside
Cell Therapeutics (Nasdaq: CTIC) and the Food and Drug Administration reached an agreement on a Special Protocol Assessment for a Phase 3 clinical trial of pacritinib.
JANA Partners acquired a 13.5% stake in Outerwall (Nasdaq: OUTR).
Macquarie upgraded BlackBerry (Nasdaq: BBRY) from an Underperform rating to a Neutral rating.
On the downside
Cooper Tire & Rubber (NYSE: CTB) filed a court complaint demanding that Apollo Tyres complete its acquisition of Cooper Tire
DryShips (NYSE: DRYS) will sell up to $200 million worth of common stock.
Atossa Genetics (Nasdaq: ATOS) recalled medical device for breast cancer detection.
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on the NYSE and by 3 to 1 on Nasdaq. The broader S&P 500 lost 7 points to 1682.
